Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 2:24 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 889–912 of 3,253 matching trials from the live ClinicalTrials.gov search.

Filters: Not yet recruiting Clear all

Conditions: Esophageal Cancer, GastroEsophageal Cancer, Gastroesophageal-junction Cancer, HER2-positive Gastric Cancer, Stomach Cancer
Interventions: Zanidatamab; Drug
Lead sponsor: Jazz Pharmaceuticals; Industry
Eligibility: 18 Years and older
Enrollment: 300 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2031
U.S. locations: 2
States / cities: Orange, California • Houston, Texas

Conditions: HIV/AIDS
Interventions: Theater/Pilot Testing; Other
Lead sponsor: Yale University; Other
Eligibility: 13 Years to 18 Years · Female only
Enrollment: 10 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026
U.S. locations: 1
States / cities: Paterson, New Jersey

Conditions: Alzheimer s Disease
Interventions: Terazosin (Hytrin), Placebo; Drug · Other
Lead sponsor: Qiang Zhang; Other
Eligibility: 50 Years to 80 Years
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2027 – 2032
U.S. locations: 1
States / cities: Iowa City, Iowa

Conditions: Photodamage of the Face, Anti Aging
Interventions: MASK LED, LED MASK AND COSMETIC FORMULA; Device · Combination Product
Lead sponsor: L'Oreal; Industry
Eligibility: 35 Years to 60 Years · Female only
Enrollment: 130 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Piscataway, New Jersey

Conditions: Elder Mistreatment, Elder Abuse, Quality of Care, Dementia, Caregiving
Interventions: Knowledge and Interpersonal Skills to Develop Enhanced Relationships, Healthy Living for the Caregiver; Behavioral
Lead sponsor: Case Western Reserve University; Other
Eligibility: 18 Years and older
Enrollment: 260 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2030
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Multiple Sclerosis, Neuropathic Pain
Interventions: glibenclamide, Placebo; Drug
Lead sponsor: University of Maryland, Baltimore; Other
Eligibility: 18 Years to 65 Years
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2029
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: ARDS (Acute Respiratory Distress Syndrome), VV ECMO
Interventions: Mechanical Power Targeted Ventilation; Procedure
Lead sponsor: University of Virginia; Other
Eligibility: 18 Years and older
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2029
U.S. locations: 1
States / cities: Charlottesville, Virginia

Conditions: Pediatric Disorder
Interventions: Acetaminophen, Ibuprofen; Drug
Lead sponsor: Baylor Research Institute; Other
Eligibility: 3 Years to 18 Years
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: Temple, Texas

Conditions: HIV Prevention, Latino Men Who Have Sex With Men, Pharmacy
Interventions: PrEP & Soccer PrEP Navigation, CVS Health brochure; Behavioral
Lead sponsor: University of Miami; Other
Eligibility: 18 Years to 54 Years · Male only
Enrollment: 800 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2029
U.S. locations: 1
States / cities: Miami, Florida

Conditions: Gonorrhea, Chlamydia, Syphilis
Interventions: On demand doxycycline hyclate 200mg, Daily doxycycline hyclate 100mg, Weekly doxycycline hyclate 100mg; Drug
Lead sponsor: University of California, Los Angeles; Other
Eligibility: 18 Years and older · Male only
Enrollment: 300 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2031
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Clostridium Infections, Methicillin-resistant Staphylococcus Aureus (MRSA), Vancomycin-Resistant Enterococci, Carbapenem-Resistant Enterobacteriaceae, Asymptomatic Infections
Interventions: Resistant Potato Starch, Maltodextrin; Drug
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 18 Years and older
Enrollment: 120 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2027 – 2030
U.S. locations: 1
States / cities: Madison, Wisconsin

Conditions: Hemophilia A, Hemophilia B
Interventions: Liver Biopsy; Procedure
Lead sponsor: St. Jude Children's Research Hospital; Other
Eligibility: 18 Years to 80 Years · Male only
Enrollment: 8 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2030
U.S. locations: 1
States / cities: Memphis, Tennessee

Conditions: Preeclampsia Severe, Preeclampsia Postpartum
Interventions: Magnesium Sulfate; Drug
Lead sponsor: Alexander Harrison; Other
Eligibility: 18 Years to 45 Years · Female only
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Lexington, Kentucky

Conditions: Physical Inactivity, Sedentary Lifestlye
Interventions: ViaHabit; Behavioral
Lead sponsor: Louisiana State University and A&M College; Other
Eligibility: 45 Years to 65 Years
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Baton Rouge, Louisiana

Conditions: Hemophilia A With Inhibitor
Interventions: efanesoctacog alpha, Emicizumab; Drug
Lead sponsor: Versiti Blood Health; Other
Eligibility: 0 Years to 17 Years
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2033
U.S. locations: 1
States / cities: Milwaukee, Wisconsin

Conditions: Chronic Kidney Diseases
Interventions: Isometric handgrip exercise training, Sham Training; Device
Lead sponsor: Emory University; Other
Eligibility: 45 Years to 85 Years
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Atlanta, Georgia

Conditions: Urethral Stricture, Urethral Diseases
Interventions: Tranexamic Acid, Urethroplasty; Drug · Procedure
Lead sponsor: Amjad Alwaal, MD, MSc, FRCSC, FACS; Other
Eligibility: 18 Years and older · Male only
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Newark, New Jersey

Conditions: Post-traumatic Stress Symptoms
Interventions: Psychosocial Intervention for Cancer-Related Post-Traumatic Stress in Young Adults; Behavioral
Lead sponsor: Zeba Ahmad, Ph.D.; Other
Eligibility: 18 Years to 39 Years
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2027 – 2030
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Eating Behaviors
Interventions: Mobile behavioral health; Behavioral
Lead sponsor: Penn State University; Other
Eligibility: 6 Years to 10 Years
Enrollment: 100 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2029
U.S. locations: 1
States / cities: State College, Pennsylvania

Conditions: Sleep Quality, Sleep and Circadian Problems
Interventions: Olly melatonin-free supplement, Placebo Supplement; Dietary Supplement
Lead sponsor: Olly, PBC; Industry
Eligibility: 4 Years to 16 Years
Enrollment: 200 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Acute Renal Failure (ARF), Acute Tubular Necrosis
Interventions: QRX-3; Drug
Lead sponsor: Ebima Clifford Okundaye; Industry
Eligibility: 10 Years to 80 Years
Enrollment: 500 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Rosharon, Texas

Conditions: Idiopathic Pulmonary Fibrosis
Interventions: Placebo, BI 3810477; Other · Biological
Lead sponsor: Boehringer Ingelheim; Industry
Eligibility: 40 Years and older
Enrollment: 70 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 13
States / cities: Tucson, Arizona • Newport Beach, California • Palo Alto, California + 10 more

Conditions: Thoracic Kyphosis
Interventions: Thoracic Mobilization, Light Touch Contact; Other
Lead sponsor: New York Institute of Technology; Other
Eligibility: 18 Years and older
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Old Westbury, New York

Conditions: Obesity & Overweight, Cardiometabolic Health Indicators
Interventions: GLP-1 dose reduction, non-GLP weight loss medication, Maintenance of GLP-1 dose, Resistance exercise regimen, Lifestyle/nutrition counseling; Drug · Behavioral
Lead sponsor: Jing Luo; Other
Eligibility: 18 Years and older
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Search by objective public record fields.

Zanidatamab Outcomes and Lived Experiences in Advanced HER2+ GEA

The Dreamer Girls Project: Adaptation of SISTA/SIHLE for HIV/AIDS and Substance Abuse Prevention Among Black Adolescent Girls

Terazosin And Metabolic Engagement in Alzheimer's Disease

Evaluation of the Efficacy and Tolerability of the LED Mask With or Without the Serum Formula on the Signs of Facial Photodamage .

Knowledge and Interpersonal Skills to Develop Enhanced Relationships (KINDER)

OER Glibenclamide for Neuropathic Pain in Multiple Sclerosis

Trial of Total Lung Protective Ventilation in Adult VV-ECMO Patients With Severe ARDS

Comparing the Difference in Pain Control in the Pediatric General Surgery Population: to Alternate or Combine Acetaminophen and Ibuprofen?

PrEP & Soccer: A Program for Pharmacy Chains to Increase PrEP Awareness and Access Among Men

Daily, Weekly, or Event-driven Doxycycline for STI Prevention Among Men Who Have Sex With Men (MSM) Engaging in Chemsex: The DOSE Non-inferiority Trial

A Clinical Trial of Resistant Potato Starch for Gut MDRO Decolonization

Liver Biopsy Following Gene Therapy For Hemophilia

Biomarkers in Management of Post Partum Preeclampsia

Roybal Via Habit Formation

Understanding Treatment Outcomes and Immunologic Mechanisms in Altuviiio Immune Tolerance Induction

Handgrip Exercise Training and CKD

REDUCER Trial (TXA in Urethroplasty)

Development of a Psychosocial Intervention to Reduce Post Traumatic Stress in Young Adult Survivors of Cancer

Bridging Rural Inclusion for Dietary Guidance and Education (BRIDGE) Study

The Pediatric Sleep Study

Use of QRX3 for Acute Tubular Necrosis Type of Renal Failure in Hospitalized Patients ( QRX-3 in ARF)

A Study to Test Whether BI 3810477 Helps People With Idiopathic Pulmonary Fibrosis When Taken With or Without Standard Treatment

Can Mobilizations Applied to the Thoracic Spine Improve Oxygen Saturation Levels and Thoracic Kyphosis in E-Cigarette Smokers?

Comparing Different Medication Regimens to Maintaining Weight Loss Among Adults With Obesity Using GLP-1s